CVS to begin selling topical CBD products, but holds off on supplements
CVS will begin selling CBD topical products in its stores, but notably leaves out dietary supplement and functional foods.
Photo © iStockphoto.com/AlenaPaulus
Curaleaf Holdings, Inc. (Wakefield, MA) announced during an earnings call that it has developed an agreement with CVS Health Corp. to begin selling its CBD products in CVS stores. The products, which include creams, sprays, and lotions infused with CBD, will be sold in 800 stores across eight states, including California, Illinois, Colorado, and Alabama. Notably, however, the pharmacy chain will not be selling any CBD products marketed as dietary supplements or foods fortified with CBD. In addition to a lineup of CBD-based lotions, tinctures, and vape pens as part of its Curaleaf Hemp line, the company also manufactures medical-grade cannabis products for the legal marijuana markets, operating 40 marijuana dispensaries across 12 states.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
